411 results
Page 4 of 21
8-K
EX-99.1
63svcwayy428
22 Dec 20
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
9:15am
8-K
EX-10.1
3ovhe6v
16 Dec 20
Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing
4:31pm
8-K
EX-99.1
t3bepbbjw0sxa2op1
16 Dec 20
Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing
4:31pm
8-K
EX-99.2
1gce6133v3
10 Sep 20
Advantages of the CiVax™ Program for Development of a Broadly Distributed Heat Stable COVID-19 Vaccine
7:32am
8-K
EX-99.1
07h3yq04jy
10 Sep 20
Advantages of the CiVax™ Program for Development of a Broadly Distributed Heat Stable COVID-19 Vaccine
7:32am
424B5
k0eg65ba la
28 Aug 20
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
9vxsc kbb45o1v
20 Jul 20
Soligenix Issues Corporate Update – Highlights Important Catalysts for Second Half of 2020
7:00am
8-K
EX-99.1
grpe3t ndlid1
30 Apr 20
Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma
7:05am
424B5
eqsbt0
10 Apr 20
Prospectus supplement for primary offering
4:16pm
424B5
94h33eeaj
20 Mar 20
Prospectus supplement for primary offering
4:06pm